{
    "id": 7066,
    "fullName": "FLT3 V592G",
    "impact": "missense",
    "proteinEffect": "gain of function",
    "geneVariantDescriptions": [
        {
            "description": "FLT3 V592G lies within a region important for maintaining kinase activity in the Flt3 protein (UniProt.org). V592G results in constitutive phosphorylation of Flt3, activation of Stat3/5, Akt, and Erk signaling, and is transforming in culture (PMID: 18068628).",
            "references": [
                {
                    "id": 2803,
                    "pubMedId": 18068628,
                    "title": "Identification of driver and passenger mutations of FLT3 by high-throughput DNA sequence analysis and functional assessment of candidate alleles.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/18068628"
                },
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 2322,
        "geneSymbol": "FLT3",
        "terms": [
            "FLT3",
            "CD135",
            "FLK-2",
            "FLK2",
            "STK1"
        ]
    },
    "variant": "V592G",
    "createDate": "06/04/2015",
    "updateDate": "09/03/2019",
    "referenceTranscriptCoordinates": {
        "id": 144609,
        "transcript": "NM_004119",
        "gDna": "chr13:g.28034144A>C",
        "cDna": "c.1775T>G",
        "protein": "p.V592G",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 2284,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Rydapt (midostaurin) inhibited FLT3-induced phosphorylation of ERK1/2 and reduced growth of transformed cells expressing FLT3 V592G in culture (PMID: 18068628).",
            "molecularProfile": {
                "id": 6924,
                "profileName": "FLT3 V592G"
            },
            "therapy": {
                "id": 810,
                "therapyName": "Midostaurin",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 2803,
                    "pubMedId": 18068628,
                    "title": "Identification of driver and passenger mutations of FLT3 by high-throughput DNA sequence analysis and functional assessment of candidate alleles.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/18068628"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 6924,
            "profileName": "FLT3 V592G",
            "profileTreatmentApproaches": [
                {
                    "id": 5045,
                    "name": "FLT3 Inhibitor",
                    "profileName": "FLT3 V592G"
                }
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 144609,
            "transcript": "NM_004119",
            "gDna": "chr13:g.28034144A>C",
            "cDna": "c.1775T>G",
            "protein": "p.V592G",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}